The Impact of the SARS-Cov2 Pandemic on a Persuasive Educational Antimicrobial Stewardship Program in a University Hospital in Southern Italy: A Pre-Post Study.
COVID-19
DDD
SARS-CoV-2
antimicrobial resistance
antimicrobial stewardship program
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
16 Nov 2021
16 Nov 2021
Historique:
received:
05
10
2021
revised:
09
11
2021
accepted:
12
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
We evaluated the effect of the pandemic on the disruption of a persuasive educational antimicrobial stewardship program (ASP) conducted in a university hospital in southern Italy. In March 2020, the ASP, which began in January 2017 and was carried out at different times in 10 wards, was stopped due to the COVID-19 pandemic. We conducted an observational study with interrupted time series analysis to compare the antibiotic consumption and costs, average length of hospital stay and in-hospital mortality between 12 months before and 9 months after the interruption. Four medical, four surgical wards and two ICUs were included in the study, for a total of 35,921 patient days. Among the medical wards we observed after the interruption a significant increase in fluoroquinolone use, with a change in trend (CT) of 0.996, The interruption of ASP during COVID-19 led to an increase in the consumption of broad-spectrum antibiotics, particularly in surgical wards and in those with a duration of ASP less than 30 months.
Identifiants
pubmed: 34827343
pii: antibiotics10111405
doi: 10.3390/antibiotics10111405
pmc: PMC8614883
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
Euro Surveill. 2020 Dec;25(49):
pubmed: 33303064
Adv Ther. 2017 Apr;34(4):854-865
pubmed: 28303388
Euro Surveill. 2020 Nov;25(45):
pubmed: 33183403
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684
pubmed: 32433765
Antibiotics (Basel). 2018 Nov 07;7(4):
pubmed: 30405004
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
Infection. 2018 Apr;46(2):215-224
pubmed: 29134582
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Clin Microbiol Infect. 2020 Jun;26(6):782.e1-782.e6
pubmed: 31678230
Lancet Infect Dis. 2017 Sep;17(9):990-1001
pubmed: 28629876
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4840-52
pubmed: 27246783
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Microbiol Infect. 2021 Jul 27;:
pubmed: 34325066
Life (Basel). 2021 May 24;11(6):
pubmed: 34073866
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD003543
pubmed: 23633313
Antibiotics (Basel). 2021 Mar 17;10(3):
pubmed: 33803069
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988